Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020

BACKGROUND: Subgroup analyses of randomized controlled trials are very common in oncology; nevertheless, the methodological approach has not been systematically evaluated. The present analysis was conducted with the aim of describing the prevalence and methodological characteristics of the subgroup...

Descripción completa

Detalles Bibliográficos
Autores principales: Paratore, C., Zichi, C., Audisio, M., Bungaro, M., Caglio, A., Di Liello, R., Gamba, T., Gargiulo, P., Mariniello, A., Reale, M.L., Perrone, F., Di Maio, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808470/
https://www.ncbi.nlm.nih.gov/pubmed/36228332
http://dx.doi.org/10.1016/j.esmoop.2022.100593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808470/
https://www.ncbi.nlm.nih.gov/pubmed/36228332
http://dx.doi.org/10.1016/j.esmoop.2022.100593

Ejemplares similares